Rethinking Fertility: 10 Lessons on Reproductive Longevity

"We've treated fertility as a binary — you're either trying or you're not. But reproductive health is a continuous signal. It tells you about hormonal balance, metabolic function, immune regulation, and even cardiovascular risk. Ignoring it until you want a baby is like ignoring your blood pressure until you have a stroke."

— Dr. Nadia Okonkwo, Tuya Care

The conversation around fertility is changing. Once confined to IVF clinics and framed almost exclusively around conception, reproductive health is now recognized as a window into whole-body wellness — and a critical piece of the longevity puzzle. For consumers, that means understanding what your fertility biomarkers reveal about your overall health. For providers, it means reproductive longevity is an emerging clinical specialty with significant demand and a clear pathway to build around.

Dr. Nadia Okonkwo, Women's Health Specialist at Tuya Care, works at the intersection of reproductive medicine and integrative health. Below, she shares ten lessons that challenge how we think about fertility — followed by a clinical framework for providers looking to incorporate fertility optimization into their practice.

1. Egg Quality Matters More Than Egg Quantity

The cultural fixation on egg count has created enormous anxiety, particularly for women in their thirties. But the clinical reality is more nuanced. "Quantity is only part of the story," Dr. Okonkwo explains. "I've seen patients with low ovarian reserve conceive naturally because their egg quality was excellent, and patients with robust reserve struggle because quality was compromised."

Egg quality — defined by chromosomal integrity, mitochondrial function, and the cellular machinery needed for healthy division — is influenced by factors that are at least partially modifiable. Oxidative stress, blood sugar regulation, sleep quality, and environmental toxin exposure all play roles. Unlike egg count, which declines predictably with age, egg quality can be actively supported through targeted lifestyle and nutritional interventions.

This distinction matters for both patients and clinicians. A low AMH result is not a fertility death sentence. It is one data point that must be interpreted alongside egg quality markers, partner factors, and the patient's broader metabolic profile.

2. AMH and FSH Testing Protocols: Timing, Context, and Clinical Interpretation

Anti-Mullerian hormone (AMH) is the most widely used biomarker for ovarian reserve, and follicle-stimulating hormone (FSH) remains a cornerstone of fertility assessment. Both are valuable — but both require careful contextual interpretation.

"AMH is a snapshot, not a destiny," Dr. Okonkwo explains. "It tells you about the pool of developing follicles at one moment in time. It does not tell you about egg quality, your ability to conceive, or your timeline to menopause." Timing matters because AMH can fluctuate based on hormonal contraceptive use, vitamin D status, and even the lab assay used. She advises against testing while on hormonal birth control, which can suppress AMH and produce misleadingly low results.

FSH should be drawn on cycle day 2-4 for accurate interpretation. An FSH above 10 mIU/mL on day 3, especially paired with low AMH, suggests diminished ovarian reserve. But elevated FSH in isolation — without supporting data — can be misleading. Estradiol must be checked concurrently: a falsely normal FSH can occur when estradiol is already elevated, suppressing FSH through negative feedback.

Dr. Okonkwo recommends testing AMH alongside day-3 FSH, estradiol, and antral follicle count (AFC) via transvaginal ultrasound. "No single marker tells the full story. The clinical picture emerges from the pattern across all four data points — and from what the patient is telling you about her cycle regularity, flow changes, and symptom trajectory."

3. Male Factor Infertility Is Vastly Underinvestigated

Male factor contributes to approximately 40-50% of infertility cases, yet the diagnostic workup for men remains dramatically less thorough than for women. "A woman will undergo blood work, ultrasound, HSG, possibly laparoscopy — all before anyone suggests a comprehensive semen analysis beyond the basic count-and-motility panel," Dr. Okonkwo observes.

"Sperm DNA fragmentation testing should be standard in any fertility evaluation. A man can have a perfectly normal semen analysis and still have high DNA fragmentation rates that significantly impair embryo development and implantation. We're missing this in the majority of cases."

— Dr. Nadia Okonkwo

Beyond DNA fragmentation, male fertility is influenced by sleep, stress, heat exposure, environmental toxins, and metabolic health. Sperm quality has declined an estimated 50% over the past four decades globally. For providers, this means every fertility consultation should include male partner evaluation from the outset — not as an afterthought once female workup is exhausted.

4. Sleep, Stress, and Toxins Are Fertility's Silent Saboteurs

Dr. Okonkwo describes sleep, stress, and environmental toxins as the "invisible triad" undermining reproductive health. Chronic sleep deprivation disrupts the pulsatile release of gonadotropin-releasing hormone (GnRH), which governs the entire reproductive hormonal cascade. Even modest sleep restriction — six hours per night instead of eight — can measurably alter LH and FSH pulsatility.

Chronic psychological stress elevates cortisol, which directly suppresses GnRH and can impair ovulation. "I've seen patients with unexplained infertility whose only identifiable factor was chronic work stress and poor sleep," Dr. Okonkwo says. "When we addressed those — genuinely addressed them, not just paid lip service — cycles normalized within two to three months."

Environmental toxins, particularly endocrine-disrupting chemicals (EDCs) like BPA, phthalates, and PFAS, interfere with hormone signaling at remarkably low concentrations. Practical steps include filtering drinking water, avoiding heated plastics, choosing fragrance-free personal care products, and eating organic produce when possible — particularly for the EWG's "Dirty Dozen." For providers, documenting environmental exposure history should be part of every fertility intake.

5. CoQ10 Is One of the Most Evidence-Backed Fertility Supplements

Coenzyme Q10 plays a critical role in mitochondrial energy production, and oocytes are among the most mitochondria-dense cells in the body. Age-related decline in CoQ10 levels correlates with reduced egg quality, and supplementation has shown promise in both animal models and human trials.

"I recommend ubiquinol — the reduced, bioavailable form — at 400-600 mg daily for patients over 35 who are planning conception," Dr. Okonkwo says. "The evidence for improved oocyte quality is compelling, and the safety profile is excellent. It's one of the few supplements where the fertility data is genuinely strong, not just theoretical."

A 2018 randomized controlled trial showed that CoQ10 supplementation in women undergoing IVF improved ovarian response, fertilization rates, and embryo quality — particularly in women over 35. For clinicians building supplement protocols, CoQ10 belongs in the evidence-based tier alongside folate, vitamin D, and omega-3 fatty acids.

6. The Thyroid-Fertility Connection Is Underappreciated

Even subclinical thyroid dysfunction — TSH levels in the "high-normal" range of 2.5-4.5 mIU/L — can impair fertility and increase miscarriage risk. The American Thyroid Association recommends a TSH below 2.5 mIU/L for women attempting conception, yet many primary care practitioners still use the standard reference range of 0.5-4.5.

"I test full thyroid panels — TSH, free T3, free T4, TPO antibodies, and thyroglobulin antibodies — on every fertility patient," Dr. Okonkwo explains. "Hashimoto's thyroiditis is remarkably common in women of reproductive age, and the autoimmune component itself may impair implantation independently of thyroid hormone levels."

This is a high-yield screening opportunity for primary care and OB/GYN providers. The standard TSH-only screen misses patients with normal TSH but elevated antibodies — a population at increased risk for pregnancy complications. Adding TPO antibodies to routine preconception screening costs very little and catches a meaningful number of at-risk patients.

7. PCOS Is a Metabolic Condition, Not Just a Reproductive One

Polycystic ovary syndrome affects an estimated 8-13% of women of reproductive age and is the leading cause of anovulatory infertility. But Dr. Okonkwo insists on reframing it. "PCOS is fundamentally a metabolic and inflammatory condition that manifests in the reproductive system. If you only treat the ovaries, you're missing the forest for the trees."

"The most effective PCOS interventions I've seen aren't fertility drugs — they're metabolic interventions. Blood sugar regulation through diet and exercise, targeted supplementation with inositol and berberine, stress management, and sleep optimization. When you address the metabolic root, ovulation often follows."

— Dr. Nadia Okonkwo

Myo-inositol has accumulated strong evidence. A 2017 meta-analysis found that myo-inositol improved ovulation rates, hormonal profiles, and metabolic parameters in women with PCOS — with efficacy comparable to metformin for some outcomes and fewer side effects. For providers, PCOS management is a natural entry point into fertility care: these patients need ongoing metabolic monitoring, lifestyle coaching, and structured follow-up — all of which support a recurring care model.

8. Fertility Preservation Timelines Are Often Misunderstood

Egg freezing has become mainstream, but many patients misunderstand the optimal timing. "The ideal window for elective egg freezing is before 35 — and ideally before 32," Dr. Okonkwo says. "By the time patients come to me at 38 saying they want to freeze eggs 'just in case,' the yield and quality are significantly reduced."

She advocates for proactive fertility counseling starting in the late twenties — not as pressure to conceive, but as informed decision-making. "I want every 28-year-old to know their AMH, understand their timeline, and have enough information to make autonomous decisions about when and whether to preserve. That's not alarmist. That's empowering."

Cost remains a barrier, with a single egg-freezing cycle running $8,000-$15,000 plus annual storage fees. But the financial calculus changes when weighed against the cost of IVF at 40, which often requires multiple cycles with lower success rates. For providers, fertility preservation counseling is a consultation service with strong patient demand and relatively low clinical overhead — it can be offered as a standalone visit or bundled into annual well-woman exams.

9. The Reproductive Microbiome Is a Frontier Worth Watching

The vaginal and endometrial microbiome are emerging as significant factors in fertility and pregnancy outcomes. A Lactobacillus-dominant vaginal microbiome is associated with higher IVF success rates, lower miscarriage risk, and reduced incidence of preterm birth. Conversely, bacterial vaginosis and dysbiotic endometrial microbiomes are linked to implantation failure and recurrent pregnancy loss.

"We're still in the early stages of understanding how to clinically intervene on the reproductive microbiome," Dr. Okonkwo acknowledges. "But the association data is strong enough that I now include vaginal microbiome testing in my workup for recurrent implantation failure. And the basics — avoiding unnecessary antibiotics, supporting gut health, using targeted probiotics — are low-risk, potentially high-reward."

Endometrial microbiome testing (such as EMMA/ALICE panels) is increasingly available and may become standard in recurrent loss and implantation failure workups. Providers who familiarize themselves with this testing now will be well-positioned as evidence matures.

10. Your Preconception Health Shapes the Next Generation

Perhaps the most profound lesson in modern reproductive science is epigenetic inheritance — the idea that parental health behaviors before conception can influence gene expression in offspring. Maternal nutrition, stress exposure, toxin burden, and metabolic status during the preconception period have all been shown to affect offspring health outcomes through epigenetic mechanisms.

"This isn't science fiction. Paternal diet and stress levels at the time of conception can alter DNA methylation patterns in sperm that persist in offspring. Maternal folate status doesn't just prevent neural tube defects — it shapes gene expression patterns that may influence disease risk for decades. The three to six months before conception may be the most consequential period for the health of the next generation."

— Dr. Nadia Okonkwo

Dr. Okonkwo recommends a minimum three-month preconception optimization period for both partners, focusing on nutrient repletion (folate, B12, vitamin D, omega-3s, CoQ10), toxin reduction, sleep optimization, stress management, and metabolic health markers like fasting insulin and HbA1c.

The Bigger Picture

These ten lessons share a common thread: fertility is not a siloed concern. It's deeply interwoven with metabolic health, immune function, environmental exposures, and lifestyle — the same factors that drive longevity and healthspan.

"When I optimize a patient's fertility, I'm also optimizing their cardiovascular risk, their metabolic health, their immune function," Dr. Okonkwo says. "The interventions are the same. Reproductive longevity and overall longevity aren't separate goals — they're the same goal, viewed through different lenses."

Whether you're planning to conceive next month or haven't thought about it yet, your reproductive health is speaking. The question is whether you're listening — and whether your provider has the tools and framework to help you act on what it's saying.